DrugPatentWatch – Make Better Decisions – Page 17

New patent for Gilead Sciences drug VEKLURY

Annual Drug Patent Expirations for VEKLURY Veklury is a drug marketed by Gilead Sciences Inc and is included in one […]
Source

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source

This chart shows the pharmaceutical companies with the most patents in Peru. Patents must be filed in each country (or, […]
Source

This chart shows the drugs with the most patents in France. Patents must be filed in each country (or, in […]
Source

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source

This chart shows the pharmaceutical companies with the most insert dosed drugs. For a different perspective, see the most popular […]
Source

Annual Drug Patent Expirations for LILETTA Liletta is a drug marketed by Medicines360 and is included in one NDA. It […]
Source

Annual Drug Patent Expirations for QINLOCK Qinlock is a drug marketed by Deciphera Pharms and is included in one NDA. […]
Source

This chart shows the drugs with the most patents in Denmark. Patents must be filed in each country (or, in […]
Source